standard]
MGFSPLLFLPFLLLTFSSADPISELTSLMDLKASLDPENLHLGSWVVAGH
PCDGSFEGVACNEKGQVANISLQGKGLAGKLSPAVGGLKHLTGLYLHYNS
LYGEIPVEIANLTELTDLYLNVNNLSGEIPPVLGNMANLQGSIPTQLSYL
KKLNVLALQSNLLTGAIPASLGNLGVLMRLDLSFNQLFGSIPAKLADAPM
LEVLDVRNNTLSGNVPLALKRLVDGFLYENNPGLCGSGFSSLRSCSDSGR
PNSDRPEPYAGGATGLPTRDIPETADLNLNCNGSPCSKKSKTSQASVAVG
VIVATVILSALGIMSFLLYRRRKQKLGSAFDISESRLSTDHVKETYRKNG
SPLVSLEYANGWDPLAEGRRFGVSQEVMQNFRLNLQEVESATQYFAEKNL
LGKSNYSVTYKGMLRDGSVVAVKRITKSSCKSEEAEFLKGLNILTSLRHE
NLVMLRGFCCSKGRGECFLVYDFVPNGSLFRYLDLKEGDGQILEWSTRVS
IIKGIAKGIEYLHDCKVNKPSLVHQNISAKNVLIDHRLKPVLSDSCLHKL
LTNDTIFSALKASAAMGYLAPEYTTTGRFTKKSDIYAFGVLVFQILSGKR
KYSTSMRATAESSSLEFIDGNLHGKFYEPEAAMLTKVAILCTHESPDDRP
SMETLVQELNS
|
IPR000719; Protein kinase, catalytic domain IPR001245; Serine-threonine/tyrosine-protein kinase IPR002290; Serine/threonine-protein kinase domain IPR013210; Leucine-rich repeat-containing N-terminal, |